GFAP (6A6) Antibody

GFAP (Glial fibrillary acidic protein) is a class-III intermediate filament. It is a cell-specific marker that distinguishes astrocytes from other glial cells during the development of the central nervous system (CNS). Defects in GFAP are a cause of Alexander disease a rare disorder of the CNS described as leukoencephalopathy. GFAP is expressed in the cortex and hippocampus, and its expression decreases following acute and chronic corticosterone treatment.